{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:20:45Z","timestamp":1783502445317,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374313"],"award-info":[{"award-number":["82374313"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03550-8","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T13:15:40Z","timestamp":1734182140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Amygdalin alleviates psoriasis-like lesions by improving skin barrier function"],"prefix":"10.1007","volume":"317","author":[{"given":"Qing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changju","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,14]]},"reference":[{"issue":"2","key":"3550_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, Symmons DP, Griffiths CE, Ashcroft DM (2013) Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 133(2):377\u2013385","journal-title":"J Invest Dermatol"},{"issue":"3","key":"3550_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jaad.2017.05.019","volume":"77","author":"S Singh","year":"2017","unstructured":"Singh S, Taylor C, Kornmehl H, Armstrong AW (2017) Psoriasis and suicidality: a systematic review and meta-analysis. J Am Acad Dermatol 77(3):425\u2013440e422","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"3550_CR3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","volume":"80","author":"CA Elmets","year":"2019","unstructured":"Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN, Armstrong AW, Connor C, Cordoro KM, Elewski BE et al (2019) Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol 80(4):1073\u20131113","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3550_CR4","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s12325-020-01346-6","volume":"37","author":"W Masson","year":"2020","unstructured":"Masson W, Lobo M, Molinero G (2020) Psoriasis and Cardiovascular Risk: a Comprehensive Review. Adv Ther 37(5):2017\u20132033","journal-title":"Adv Ther"},{"issue":"10","key":"3550_CR5","first-page":"667","volume":"52","author":"Psoriasis Committee of the Chinese Medical Association","year":"2019","unstructured":"Psoriasis Committee of the Chinese Medical Association (2019) Dermatology and Venereology Branch. Guidelines for the treatment of psoriasis in China (2018 full version). Chin J Dermatology 52(10):667\u2013710","journal-title":"Chin J Dermatology"},{"issue":"2","key":"3550_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","volume":"84","author":"CA Elmets","year":"2021","unstructured":"Elmets CA, Korman NJ, Prater EF, Wong EB, Rupani RN, Kivelevitch D, Armstrong AW, Connor C, Cordoro KM, Davis DMR et al (2021) Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol 84(2):432\u2013470","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3550_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.det.2018.07.004","volume":"37","author":"HJ Kim","year":"2019","unstructured":"Kim HJ, Lebwohl MG (2019) Biologics and Psoriasis: the beat goes on. Dermatol Clin 37(1):29\u201336","journal-title":"Dermatol Clin"},{"key":"3550_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.intimp.2019.01.054","volume":"69","author":"A Wang","year":"2019","unstructured":"Wang A, Wei J, Lu C, Chen H, Zhong X, Lu Y, Li L, Huang H, Dai Z, Han L (2019) Genistein suppresses psoriasis-related inflammation through a STAT3-NF-\u03baB-dependent mechanism in keratinocytes. Int Immunopharmacol 69:270\u2013278","journal-title":"Int Immunopharmacol"},{"key":"3550_CR9","unstructured":"Zhong X, Leng L, Chuan Jian L, Effect of bitter amygdalin on lipopolysaccharide-induced inflammation in a RAW264.7 macrophage model. New Drugs in Chinese Medicine and Clinical Pharmacology, 29(03): pp. 257-263"},{"key":"3550_CR10","doi-asserted-by":"crossref","unstructured":"Lef\u00e8vre-Utile, Braun A, Haftek C, Aubin M (2021) Five functional aspects of the epidermal barrier. Int J Mol Sci 22(21)","DOI":"10.3390\/ijms222111676"},{"key":"3550_CR11","doi-asserted-by":"publisher","first-page":"1239598","DOI":"10.3389\/fimmu.2023.1239598","volume":"14","author":"S Morizane","year":"2023","unstructured":"Morizane S, Mukai T, Sunagawa K, Tachibana K, Kawakami Y, Ouchida M (2023) Input\/output cytokines in epidermal keratinocytes and the involvement in inflammatory skin diseases. Front Immunol 14:1239598","journal-title":"Front Immunol"},{"issue":"7","key":"3550_CR12","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U et al (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol 18(7):e3000410","journal-title":"PLoS Biol"},{"key":"3550_CR13","doi-asserted-by":"publisher","first-page":"e9232","DOI":"10.7717\/peerj.9232","volume":"8","author":"S Albogami","year":"2020","unstructured":"Albogami S, Hassan A, Ahmed N, Alnefaie A, Alattas A, Alquthami L, Alharbi A (2020) Evaluation of the effective dose of amygdalin for the improvement of antioxidant gene expression and suppression of oxidative damage in mice. PeerJ 8:e9232","journal-title":"PeerJ"},{"key":"3550_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.biopha.2018.12.096","volume":"111","author":"F Tang","year":"2019","unstructured":"Tang F, Fan K, Wang K, Bian C (2019) Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-\u03baB and Nrf2\/NQO1 signalling pathways. Biomed Pharmacother 111:527\u2013536","journal-title":"Biomed Pharmacother"},{"key":"3550_CR15","unstructured":"Huang J, Chen Z, Zheng Q, Sun R Equivalence dose conversion between animals and from animals to humans in pharmacological experiments. Chinese Journal of Clinical Pharmacology and Therapeutics, 9(9), 1069-1072"},{"key":"3550_CR16","doi-asserted-by":"crossref","unstructured":"Barber C, Boiko S (2022) Tape stripping: investigational, diagnostic, and therapeutic uses in dermatology. Clin Dermatol 40(4):355\u2013362","DOI":"10.1016\/j.clindermatol.2022.02.008"},{"issue":"7","key":"3550_CR17","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.nano.2014.04.004","volume":"10","author":"A Ostrowski","year":"2014","unstructured":"Ostrowski A, Nordmeyer D, Boreham A, Brodwolf R, Mundhenk L, Fluhr JW, Lademann J, Graf C, R\u00fchl E, Alexiev U et al (2014) Skin barrier disruptions in tape stripped and allergic dermatitis models have no effect on dermal penetration and systemic distribution of AHAPS-functionalized silica nanoparticles. Nanomedicine 10(7):1571\u20131581","journal-title":"Nanomedicine"},{"issue":"3","key":"3550_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000484443","volume":"31","author":"EKB Pfannes","year":"2018","unstructured":"Pfannes EKB, Weiss L, Hadam S, Gonnet J, Combardi\u00e8re B, Blume-Peytavi U, Vogt A (2018) Physiological and molecular effects of in vivo and ex vivo mild skin barrier disruption. Skin Pharmacol Physiol 31(3):115\u2013124","journal-title":"Skin Pharmacol Physiol"},{"key":"3550_CR19","doi-asserted-by":"publisher","first-page":"118843","DOI":"10.1016\/j.ijpharm.2019.118843","volume":"574","author":"P Dong","year":"2020","unstructured":"Dong P, Nikolaev V, Kr\u00f6ger M, Zoschke C, Darvin ME, Witzel C, Lademann J, Patzelt A, Sch\u00e4fer-Korting M, Meinke MC (2020) Barrier-disrupted skin: quantitative analysis of tape and cyanoacrylate stripping efficiency by multiphoton tomography. Int J Pharm 574:118843","journal-title":"Int J Pharm"},{"issue":"1","key":"3550_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40659-020-00316-0","volume":"53","author":"J Gao","year":"2020","unstructured":"Gao J, Chen F, Fang H, Mi J, Qi Q, Yang M (2020) Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. Biol Res 53(1):48","journal-title":"Biol Res"},{"issue":"227","key":"3550_CR21","first-page":"300","volume":"38","author":"Z Zdrojewicz","year":"2015","unstructured":"Zdrojewicz Z, Otlewska A, Hackemer P, Otlewska A (2015) [Amygdalin - structure and clinical significance]. Pol Merkur Lekarski 38(227):300\u2013303","journal-title":"Pol Merkur Lekarski"},{"key":"3550_CR22","doi-asserted-by":"publisher","first-page":"112717","DOI":"10.1016\/j.jep.2020.112717","volume":"254","author":"XY He","year":"2020","unstructured":"He XY, Wu LJ, Wang WX, Xie PJ, Chen YH, Wang F (2020) Amygdalin - A pharmacological and toxicological review. J Ethnopharmacol 254:112717","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"3550_CR23","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.1038\/s41598-022-10517-0","volume":"12","author":"AA Attia","year":"2022","unstructured":"Attia AA, Salama AF, Eldiasty JG, Mosallam SAE, El-Naggar SA, El-Magd MA, Nasser HM, Elmetwalli A (2022) Amygdalin potentiates the anti-cancer effect of Sorafenib on Ehrlich ascites carcinoma and ameliorates the associated liver damage. Sci Rep 12(1):6494","journal-title":"Sci Rep"},{"key":"3550_CR24","doi-asserted-by":"publisher","first-page":"590929","DOI":"10.3389\/fphar.2020.590929","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Jia Q, Zhang Y, Wei J, Liu P (2020) Amygdalin attenuates atherosclerosis and plays an anti-inflammatory role in ApoE knock-out mice and bone marrow-derived macrophages. Front Pharmacol 11:590929","journal-title":"Front Pharmacol"},{"issue":"11","key":"3550_CR25","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1600-0625.2005.00368.x","volume":"14","author":"A Baroni","year":"2005","unstructured":"Baroni A, Paoletti I, Greco R, Satriano RA, Ruocco E, Tufano MA, Perez JJ (2005) Immunomodulatory effects of a set of amygdalin analogues on human keratinocyte cells. Exp Dermatol 14(11):854\u2013859","journal-title":"Exp Dermatol"},{"key":"3550_CR26","doi-asserted-by":"publisher","first-page":"154018","DOI":"10.1016\/j.phymed.2022.154018","volume":"99","author":"C Zhang","year":"2022","unstructured":"Zhang C, Zhang D, Wang Y, Zhang L, Qi S, Fang Q, Xu Y, Chen J, Cheng X, Liu P et al (2022) Pharmacokinetics and anti-liver fibrosis characteristics of amygdalin: key role of the deglycosylated metabolite prunasin. Phytomedicine 99:154018","journal-title":"Phytomedicine"},{"issue":"6","key":"3550_CR27","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1007\/s10753-013-9670-7","volume":"36","author":"I Paoletti","year":"2013","unstructured":"Paoletti I, De Gregorio V, Baroni A, Tufano MA, Donnarumma G, Perez JJ (2013) Amygdalin analogues inhibit IFN-\u03b3 signalling and reduce the inflammatory response in human epidermal keratinocytes. Inflammation 36(6):1316\u20131326","journal-title":"Inflammation"},{"issue":"11","key":"3550_CR28","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1111\/exd.14390","volume":"30","author":"N Gago-L\u00f3pez","year":"2021","unstructured":"Gago-L\u00f3pez N, Lagunas Arnal C, Perez JJ, Wagner EF (2021) Topical application of an amygdalin analogue reduces inflammation and keratinocyte proliferation in a psoriasis mouse model. Exp Dermatol 30(11):1662\u20131674","journal-title":"Exp Dermatol"},{"issue":"7","key":"3550_CR29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.4155\/fmc.13.27","volume":"5","author":"JJ Perez","year":"2013","unstructured":"Perez JJ (2013) Amygdalin analogs for the treatment of psoriasis. Future Med Chem 5(7):799\u2013808","journal-title":"Future Med Chem"},{"issue":"10281","key":"3550_CR30","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J (2021) Psoriasis. Lancet 397(10281):1301\u20131315","journal-title":"Lancet"},{"issue":"9","key":"3550_CR31","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP et al (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol 182(9):5836\u20135845","journal-title":"J Immunol"},{"key":"3550_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.biopha.2018.11.092","volume":"110","author":"DH Wu","year":"2019","unstructured":"Wu DH, Zhang MM, Li N, Li X, Cai QW, Yu WL, Liu LP, Zhu W, Lu CJ (2019) PSORI-CM02 alleviates IMQ-induced mouse dermatitis via differentially regulating pro- and anti-inflammatory cytokines targeting of Th2 specific transcript factor GATA3. Biomed Pharmacother 110:265\u2013274","journal-title":"Biomed Pharmacother"},{"issue":"1\u20132","key":"3550_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cca.2008.04.005","volume":"394","author":"AT Pietrzak","year":"2008","unstructured":"Pietrzak AT, Zalewska A, Chodorowska G, Krasowska D, Michalak-Stoma A, Nockowski P, Osemlak P, Paszkowski T, Roli\u0144ski JM (2008) Cytokines and anticytokines in psoriasis. Clin Chim Acta 394(1\u20132):7\u201321","journal-title":"Clin Chim Acta"},{"issue":"1\u20132","key":"3550_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijpharm.2009.09.044","volume":"384","author":"M Machado","year":"2010","unstructured":"Machado M, Salgado TM, Hadgraft J, Lane ME (2010) The relationship between transepidermal water loss and skin permeability. Int J Pharm 384(1\u20132):73\u201377","journal-title":"Int J Pharm"},{"key":"3550_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.tiv.2018.04.009","volume":"51","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Murawsky M, LaCount T, Kasting GB, Li SK (2018) Transepidermal water loss and skin conductance as barrier integrity tests. Toxicol Vitro 51:129\u2013135","journal-title":"Toxicol Vitro"},{"key":"3550_CR36","doi-asserted-by":"crossref","unstructured":"Orsmond A, Bereza-Malcolm L, Lynch T, March L, Xue M (2021) Skin barrier dysregulation in Psoriasis. Int J Mol Sci 22(19)","DOI":"10.3390\/ijms221910841"},{"issue":"5","key":"3550_CR37","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1083\/jcb.201404147","volume":"211","author":"V Kumar","year":"2015","unstructured":"Kumar V, Bouameur JE, B\u00e4r J, Rice RH, Hornig-Do HT, Roop DR, Schwarz N, Brodesser S, Thiering S, Leube RE et al (2015) A keratin scaffold regulates epidermal barrier formation, mitochondrial lipid composition, and activity. J Cell Biol 211(5):1057\u20131075","journal-title":"J Cell Biol"},{"issue":"9","key":"3550_CR38","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/1346-8138.14489","volume":"45","author":"E Proksch","year":"2018","unstructured":"Proksch E (2018) pH in nature, humans and skin. J Dermatol 45(9):1044\u20131052","journal-title":"J Dermatol"},{"issue":"1","key":"3550_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s12272-021-01305-x","volume":"44","author":"Y Kim","year":"2021","unstructured":"Kim Y, Lim KM (2021) Skin barrier dysfunction and filaggrin. Arch Pharm Res 44(1):36\u201348","journal-title":"Arch Pharm Res"},{"issue":"Pt 17","key":"3550_CR40","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1242\/jcs.114.17.3069","volume":"114","author":"A Kalinin","year":"2001","unstructured":"Kalinin A, Marekov LN, Steinert PM (2001) Assembly of the epidermal cornified cell envelope. J Cell Sci 114(Pt 17):3069\u20133070","journal-title":"J Cell Sci"},{"issue":"28","key":"3550_CR41","doi-asserted-by":"publisher","first-page":"17763","DOI":"10.1074\/jbc.273.28.17763","volume":"273","author":"LN Marekov","year":"1998","unstructured":"Marekov LN, Steinert PM (1998) Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. J Biol Chem 273(28):17763\u201317770","journal-title":"J Biol Chem"},{"issue":"4","key":"3550_CR42","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nrm1619","volume":"6","author":"E Candi","year":"2005","unstructured":"Candi E, Schmidt R, Melino G (2005) The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 6(4):328\u2013340","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"3550_CR43","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1292\/jvms.70.841","volume":"70","author":"K Shimada","year":"2008","unstructured":"Shimada K, Yoshihara T, Yamamoto M, Konno K, Momoi Y, Nishifuji K, Iwasaki T (2008) Transepidermal water loss (TEWL) reflects skin barrier function of dog. J Vet Med Sci 70(8):841\u2013843","journal-title":"J Vet Med Sci"},{"issue":"2","key":"3550_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1600-0625.1997.tb00154.x","volume":"6","author":"LC Wood","year":"1997","unstructured":"Wood LC, Stalder AK, Liou A, Campbell IL, Grunfeld C, Elias PM, Feingold KR (1997) Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin. Exp Dermatol 6(2):98\u2013104","journal-title":"Exp Dermatol"},{"key":"3550_CR45","doi-asserted-by":"publisher","first-page":"788940","DOI":"10.3389\/fimmu.2021.788940","volume":"12","author":"P Hu","year":"2021","unstructured":"Hu P, Wang M, Gao H, Zheng A, Li J, Mu D, Tong J (2021) The role of helper T cells in Psoriasis. Front Immunol 12:788940","journal-title":"Front Immunol"},{"issue":"4","key":"3550_CR46","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaci.2019.06.019","volume":"144","author":"K Sakurai","year":"2019","unstructured":"Sakurai K, Dainichi T, Garcet S, Tsuchiya S, Yamamoto Y, Kitoh A, Honda T, Nomura T, Egawa G, Otsuka A et al (2019) Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitis. J Allergy Clin Immunol 144(4):1036\u20131049","journal-title":"J Allergy Clin Immunol"},{"key":"3550_CR47","doi-asserted-by":"publisher","first-page":"806844","DOI":"10.3389\/fphar.2021.806844","volume":"12","author":"H Chen","year":"2021","unstructured":"Chen H, Wang C, Tang B, Yu J, Lu Y, Zhang J, Yan Y, Deng H, Han L, Li S et al (2021) P. Granatum Peel Polysaccharides Ameliorate Imiquimod-Induced Psoriasis-Like Dermatitis in mice via suppression of NF-\u03baB and STAT3 pathways. Front Pharmacol 12:806844","journal-title":"Front Pharmacol"},{"key":"3550_CR48","doi-asserted-by":"crossref","unstructured":"Chen X, Chen Y, Stanton C, Ross RP, Zhao J, Chen W, Yang B (2023) Dose-response efficacy and mechanisms of orally administered Bifidobacterium breve CCFM683 on IMQ-Induced Psoriasis in mice. Nutrients 15(8)","DOI":"10.3390\/nu15081952"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03550-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03550-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03550-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T14:02:54Z","timestamp":1734184974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03550-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,14]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3550"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03550-8","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,14]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This animal experiment was reviewed and approved by the Animal Care and Use Committee of Guangzhou University of Traditional Chinese Medicine (2020038) and followed the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The author declares no conflict of interest with this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"115"}}